IGF1 and risk of additional breast cancer in the WHEL study.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Endocrine-Related Cancer

• Publication date

  2011-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1530/ERC-10-0121PMID 21263044
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Adiponectin and breast cancer

  2011cited by this paper
• Clinically defined type 2 diabetes mellitus and prognosis in early-stage breast cancer.

  2011cited by this paper
• Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies

  2010influential reference
• Randomized double-blind 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in high-risk premenopausal women.

  2009cited by this paper
• Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women.

  2009cited by this paper
• Serum insulin-like growth factors I and II, insulin-like growth factor binding protein-3 and risk of breast cancer in the Japan Collaborative Cohort study.

  2009cited by this paper
• Proliferative effects of insulin analogues on mammary epithelial cells

  2008cited by this paper
• Serum Insulin-Like Growth Factor-I and Platelet-Derived Growth Factor as Biomarkers of Breast Cancer Prognosis

  2008cited by this paper
• The impact of diabetes on survival following breast cancer

  2008influential reference
• Total and high-molecular-weight adiponectin in breast cancer: in vitro and in vivo studies.

  2007cited by this paper
• Validation of the WHI brief physical activity questionnaire among women diagnosed with breast cancer.

  2007cited by this paper
• IGF-I, IGFBP-3 and breast cancer risk in women: The European Prospective Investigation into Cancer and Nutrition (EPIC).

  2006influential reference
• Insulin-Like Growth Factor I, Insulin-Like Growth Factor I Binding Protein 1, Insulin, Glucose, and Leptin Serum Levels Are Not Influenced by a Reduced-Fat, High-Fiber Diet Intervention

  2006cited by this paper
• Plasma adiponectin concentrations and risk of incident breast cancer.

  2006cited by this paper
• Achieving substantial changes in eating behavior among women previously treated for breast cancer--an overview of the intervention.

  2005cited by this paper
• Is leptin a mediator of adverse prognostic effects of obesity in breast cancer?

  2005cited by this paper
• Adiponectin and breast cancer risk.

  2004influential reference
• Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis.

  2004influential reference
• Plasma Leptin and Breast Cancer Risk: A Prospective Study in Northern Sweden

  2004cited by this paper
• Leptin expression in breast nipple aspirate fluid (NAF) and serum is influenced by body mass index (BMI) but not by the presence of breast cancer.

  2004cited by this paper
• Study design: Evaluating gene–environment interactions in the etiology of breast cancer – the WECARE study

  2004cited by this paper
• Association of serum adiponectin levels with breast cancer risk.

  2003cited by this paper
• Leptin levels in type 2 diabetes: associations with measures of insulin resistance and insulin secretion.

  2003cited by this paper
• Circulating levels of insulin‐like growth factor I, its binding proteins ‐1,‐2, ‐3, C‐peptide and risk of postmenopausal breast cancer

  2003cited by this paper
• Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women.

  2002cited by this paper
• Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.

  2002cited by this paper
• Fasting glucose is a risk factor for breast cancer: a prospective study.

  2002cited by this paper
• Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans.

  2002cited by this paper
• Prospective study of IGF-I, IGF-binding proteins, and breast cancer risk, in Northern and Southern Sweden

  2002influential reference
• Disruption of Adiponectin Causes Insulin Resistance and Neointimal Formation*

  2002cited by this paper
• A randomized trial of the effect of a plant-based dietary pattern on additional breast cancer events and survival: the Women's Healthy Eating and Living (WHEL) Study.

  2002influential reference
• Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study.

  2002influential reference
• Insulin-resistant patients with type 2 diabetes mellitus have higher serum leptin levels independently of body fat mass

  2002cited by this paper
• Serum insulin‐like growth factor‐I and breast cancer

  2000cited by this paper
• Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.

  2000cited by this paper
• Leptin expression in colorectal and breast cancer patients.

  2000cited by this paper
• Leptin and insulin growth factor I in relation to breast cancer (Greece)

  2000influential reference
• Cooperative interaction between mutant p53 and des(1-3)IGF-I accelerates mammary tumorigenesis

  2000cited by this paper
• Plasma Insulin-Like Growth Factor-I and Serum IGF-Binding Protein 3 Can Be Associated with the Progression of Breast Cancer, and Predict the Risk of Recurrence and the Probability of Survival in African-American and Hispanic Women

  1999cited by this paper
• Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

  1998cited by this paper
• Leptin expression in human mammary epithelial cells and breast milk.

  1998cited by this paper
• Circulating concentrations of insulin-like growth factor-I and risk of breast cancer.

  1998cited by this paper
• Altered serum levels of insulin-like growth-factor binding proteins in breast cancer patients

  1998cited by this paper
• Igf-independent regulation of breast cancer growth by IGF binding proteins

  1998cited by this paper
• Tamoxifen for early breast cancer: an overview of the randomised trials

  1998cited by this paper
• Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions.

  1997cited by this paper
• Insulin-like Growth Factors and Cancer

  1995cited by this paper
• Nutritional regulation of the insulin-like growth factors.

  1994cited by this paper
• Nutritional regulation of hormones and growth factors that control mammalian growth

  1994cited by this paper
• Expression of insulin‐like growth factor binding proteins in human breast cancer correlates with estrogen receptor status

  1993cited by this paper
• Insulin resistance and breast‐cancer risk

  1992cited by this paper
• Insulin-like growth factors and cancer.

  1992cited by this paper
• Asymptotic Theory for Nested Case-Control Sampling in the Cox Regression Model

  1992cited by this paper
• Insulin receptor expression and function in human breast cancer cell lines.

  1992cited by this paper
• Nested case-control and case-cohort methods of sampling from a cohort: a critical comparison.

  1990cited by this paper
• The impact of diabetes ON survival in acute myocardial infarction: The TAMI experience

  1990cited by this paper
• Biased selection of controls for case-control analyses of cohort studies.

  1984cited by this paper

• Effect of s-Klotho Protein, GPX, Visfatin, Leptin and ROS of Iraqi Women with Breast Cancer

  2024cites this paper
• Associations between circulating obesity-related biomarkers and prognosis in female breast cancer survivors: a systematic review of observational data in women enrolled in lifestyle intervention trials

  2022influential citation
• Role of the IGF-1 Axis in Overcoming Resistance in Breast Cancer

  2021cites this paper
• A molecular link between diabetes and breast cancer: Therapeutic potential of repurposing incretin-based therapies for breast cancer.

  2021cites this paper
• Association of CYP2D6 genotype and tamoxifen metabolites with breast cancer recurrence in a low-dose trial

  2021cites this paper
• Key genes affecting the progression of nasopharyngeal carcinoma identified by RNA-sequencing and bioinformatic analysis

  2021cites this paper
• Association between diabetes, obesity, aging, and cancer: review of recent literature

  2020cites this paper
• Associations Between Circulating Insulin-Like Growth Factor 1 and Mortality in Women With Invasive Breast Cancer

  2020cites this paper
• The insulin-like growth factor family and breast cancer prognosis: A prospective cohort study among postmenopausal women in Denmark.

  2019cites this paper
• How the association between obesity and inflammation may lead to insulin resistance and cancer.

  2019cites this paper
• Association of serum adiponectin with breast cancer

  2019cites this paper
• Serum IGF-1, IGFBP-3 levels and circulating tumor cells (CTCs) in early breast cancer patients.

  2017cites this paper
• Could IGF-I levels play a neuroprotective role in patients with large vestibular schwannomas?

  2017cites this paper
• Advanced Hepatic Fibrosis in Fatty Liver Disease Linked to Hyperplastic Colonic Polyp

  2017cites this paper
• Resistance to Targeted Therapies in Breast Cancer.

  2016cites this paper
• Current perspectives between metabolic syndrome and cancer

  2016cites this paper
• Impact of Weight Loss on Plasma Leptin and Adiponectin in Overweight-to-Obese Post Menopausal Breast Cancer Survivors

  2015cites this paper
• The insulin-like growth factor 1 axis in prognosis and treatment of breast cancer

  2014cites this paper
• Clinical significance of serum insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3) in patients with breast cancer

  2014cites this paper
• Circulating adiponectin and breast cancer risk: a systematic review and meta-analysis.

  2014cites this paper
• Association of IGF1R polymorphisms with the development of HBV-related hepatocellular carcinoma.

  2014cites this paper
• Associations of insulin‐like growth factor and insulin‐like growth factor binding protein‐3 with mortality in women with breast cancer

  2013cites this paper
• Insulin resistance and cancer: the role of insulin and IGFs.

  2013influential citation
• Ovarian cysts during tamoxifen use may affect the prognostic markers of premenopausal breast cancer

  2013cites this paper
• Carbohydrate Intake and Outcomes among Postmenopausal Breast Cancer Survivors

  2013cites this paper
• Suppression of Mammary Tumorigenesis by a Gemini Vitamin D Analog and a Synthetic Triterpenoid

  2013cites this paper
• Prognostic value of insulin-like growth factor 1 and insulin-like growth factor binding protein 3 blood levels in breast cancer.

  2013cites this paper
• Serum insulin and C-peptide concentration and breast cancer: a meta-analysis

  2013cites this paper
• Identification of the IGF1/PI3K/NF κB/ERK gene signalling networks associated with chemotherapy resistance and treatment response in high-grade serous epithelial ovarian cancer

  2013cites this paper
• Nutrition in complementary and alternative medicine.

  2012cites this paper
• Insulinemia and the risk of breast cancer and its relapse

  2012cites this paper
• International Journal of Molecular Sciences the Obesity-breast Cancer Conundrum: an Analysis of the Issues 2. Breast Cancer and Obesity: What Is the Connection?

  year unknowncites this paper